Home Healthcare Market to be Worth $514.5 Billion by 2030
According to the latest report by
Meticulous Research®, the global home healthcare market is projected to reach
$514.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.9%
over the forecast period. This growth is driven by several key factors,
including the rising prevalence of chronic diseases and the increasing adoption
of home healthcare services as a cost-effective alternative to expensive
hospital care. Additionally, the growing demand for home-based care due to
infectious disease concerns, opportunities in emerging markets, and the launch
of advanced home healthcare technologies are expected to fuel market expansion.
Download free sample
report here: https://www.meticulousresearch.com/download-sample-report/cp_id=1280?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=16-09-2024
- Home
Healthcare Market: Future Outlook
The home healthcare market is
segmented into offerings, services, applications, and geography. The study also
evaluates key industry competitors and provides insights at both regional and
country levels.
- Market
Segmentation:
- By
Offering:
- Home Tests and Patient Monitoring Equipment (e.g., fertility
tests, pregnancy tests, blood pressure monitors, oximeters, thermometers,
diabetes management tools)
- Home Therapeutic Equipment (e.g., respiratory therapy equipment,
dialysis equipment, IV equipment)
- Patient Support Equipment (e.g., mobility assist devices like
wheelchairs, medical furniture, and bathroom safety equipment)
In 2023, the home therapeutic
equipment segment is expected to hold the largest market share due to the
increasing incidence of chronic conditions such as kidney disease and
respiratory disorders, alongside the availability of rental therapeutic
equipment.
Browse in depth: https://www.meticulousresearch.com/product/home-healthcare-market-1280?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=16-09-2024
- By
Services:
- The market is categorized into rehabilitation services, infusion
services, skilled care/nursing, unskilled care services, telehealth
services, hospice care, respiratory therapy, and others. The skilled
care/nursing segment is expected to witness the highest growth, driven by
the growing elderly population requiring long-term care, the burden of
chronic diseases, rising awareness of telehealth, and cost advantages
over hospital services.
- By
Application:
- The home healthcare market is divided into several applications,
including cardiovascular diseases, diabetes, respiratory diseases,
mobility disorders, pregnancy care, cancer, and wound care. The diabetes
segment is projected to account for the largest share of the market in
2023 due to the increasing global prevalence of diabetes and the need for
continuous glucose monitoring among patients.
- Geographic
Insights:
The report provides a
comprehensive geographic analysis, covering regions such as:
- North
America (U.S. and Canada)
- Europe
(Germany, U.K., France, Italy, Spain)
- Asia-Pacific
(China, Japan, India, and others)
- Latin
America (Brazil, Mexico, and others)
- Middle
East & Africa
Download request sample
report here: https://www.meticulousresearch.com/request-sample-report/cp_id=1280?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=16-09-2024
In 2023, North America is expected to
lead the market, with the U.S. being the largest contributor. The U.S. market
growth is attributed to high disposable incomes, a growing number of patients
with chronic conditions, and government initiatives promoting home healthcare
services. Europe and Asia-Pacific are also significant markets, with
Asia-Pacific experiencing rapid growth due to the rising demand for home
healthcare services in developing economies.
- Key
Players:
Prominent companies in
the home healthcare market include:
- Abbott
Laboratories (U.S.)
- Amedisys,
Inc. (U.S.)
- Owens
& Minor (U.S.)
- B.
Braun SE (Germany)
- Baxter
International, Inc. (U.S.)
- BAYADA
Home Health Care (U.S.)
- Convatec
(U.K.)
- Halyard
Health, Inc. (U.S.)
- Covidien
(Ireland)
- Fisher
& Paykel (New Zealand)
- Fresenius
Medical (Germany)
- GE
Healthcare (U.S.)
- Johnson
& Johnson (U.S.)
- F.
Hoffmann-La Roche AG (Switzerland)
In summary, the home healthcare
market is on a strong growth trajectory, driven by an aging population,
increasing chronic diseases, technological innovations, and cost-saving
potential compared to traditional hospital care. The U.S. and North America are
leading the market, while opportunities for further growth are also emerging in
developing regions.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
*Related
research
Latin
America home healthcare market: https://www.meticulousresearch.com/download-sample-report/cp_id=1287?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=16-09-2024
Comments
Post a Comment